Moreover, HCC patients with higher BUB1B expression had shorter recurrence‐free survival (hazard ratio = 1.7; P = .00072) and worse overall survival (hazard ratio = 1.7; P = .0028). Here, BUB1B is linked to hepatocellular carcinoma.